Universal Biosensors Inc (UBI) financial statements (2021 and earlier)

Company profile

Business Address 1 CORPORATE AVENUE
VICTORIA, 3178
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24301226201416
Cash and cash equivalents24301226201416
Restricted cash and investments220    
Receivables00504534
Inventory, net of allowances, customer advances and progress billings2111100
Inventory2111100
Prepaid expense0001111
Other current assets43118109
Total current assets:31376433352930
Noncurrent Assets
Property, plant and equipment45610121314
Intangible assets, net (including goodwill)1416     
Intangible assets, net (excluding goodwill)1416     
Restricted cash and investments250    
Other noncurrent assets   3333
Other undisclosed noncurrent assets4      
Total noncurrent assets:2526613151617
TOTAL ASSETS:56637046504548
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2283443
Accounts payable0110110
Accrued liabilities1121222
Employee-related liabilities1112211
Taxes payable  4    
Deferred revenue23
Debt    000
Business combination, contingent consideration, liability22     
Deferred revenue and credits2  2
Other liabilities3333201
Other undisclosed current liabilities1 2    
Total current liabilities:910138656
Noncurrent Liabilities
Long-term debt and lease obligation4  15151514
Long-term debt, excluding current maturities0  15151514
Operating lease, liability4 
Liabilities, other than long-term debt67361074
Deferred revenue and credits361 
Deferred revenue 1
Asset retirement obligations3333333
Deferred income tax liabilities33
Other liabilities    131
Other undisclosed noncurrent liabilities0044663
Total noncurrent liabilities:97625312721
Total liabilities:18171933373228
Stockholders' equity
Stockholders' equity attributable to parent, including:38455113131320
Common stock0000000
Additional paid in capital94939493939494
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(48)(43)(80)(80)(81)(74)(65)
Other undisclosed stockholders' equity attributable to parent(8)(5)38(1)1(7)(9)
Total stockholders' equity:38455113131320
TOTAL LIABILITIES AND EQUITY:56637046504548

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues377025191710
Revenue, net25191710
Cost of revenue
(Cost of Goods and Services Sold)
(3)(4)(3)(4)(1)(1)(1)
Other undisclosed gross profit  (0)(0)   
Gross profit:13672118159
Operating expenses(13)(14)(21)(20)(21)(26)(28)
Other undisclosed operating income      6
Operating income (loss):(13)(10)461(4)(10)(14)
Nonoperating income (expense)54(5)(2)544
Investment income, nonoperating0100000
Foreign currency transaction gain, before tax      1
Other nonoperating income (expense)20 (0)889
Interest and debt expense(0) (3)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes    000
Income (loss) from continuing operations before equity method investments, income taxes:(8)(6)39(1)1(7)(9)
Other undisclosed income (loss) from continuing operations before income taxes0 30(0)  
Income (loss) from continuing operations before income taxes:(8)(6)42(1)1(7)(9)
Income tax expense (benefit) 1(4)    
Net income (loss) available to common stockholders, diluted:(8)(5)38(1)1(7)(9)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(8)(5)38(1)1(7)(9)
Other comprehensive income (loss)0(0)(0)(0)0  
Comprehensive income (loss), net of tax, attributable to parent:(8)(5)38(1)1(7)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: